FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563676178> ?p ?o ?g. }

• W2563676178 endingPage "28" @default.
• W2563676178 startingPage "15" @default.
• W2563676178 abstract "Antisense-mediated exon skipping is a promising approach for the treatment of Duchenne muscular dystrophy (DMD), a rare life-threatening genetic disease due to dystrophin deficiency. Such an approach can restore the disrupted reading frame of dystrophin pre-mRNA, generating a truncated form of the protein. Alternatively, antisense therapy can be used to induce destructive exon skipping of myostatin pre-mRNA, knocking down myostatin expression to enhance muscle strength and reduce fibrosis. We have reported previously that intramuscular or intraperitoneal antisense administration inducing dual exon skipping of dystrophin and myostatin pre-mRNAs was beneficial in mdx mice, a mouse model of DMD, although therapeutic effects were muscle type restricted, possibly due to the delivery routes used. Here, following systemic intravascular antisense treatment, muscle strength and body activity of treated adult mdx mice increased to the levels of healthy controls. Importantly, hallmarks of muscular dystrophy were greatly improved in mice receiving the combined exon-skipping therapy, as compared to those receiving dystrophin antisense therapy alone. Our results support the translation of antisense therapy for dystrophin restoration and myostatin inhibition into the clinical setting for DMD. Antisense-mediated exon skipping is a promising approach for the treatment of Duchenne muscular dystrophy (DMD), a rare life-threatening genetic disease due to dystrophin deficiency. Such an approach can restore the disrupted reading frame of dystrophin pre-mRNA, generating a truncated form of the protein. Alternatively, antisense therapy can be used to induce destructive exon skipping of myostatin pre-mRNA, knocking down myostatin expression to enhance muscle strength and reduce fibrosis. We have reported previously that intramuscular or intraperitoneal antisense administration inducing dual exon skipping of dystrophin and myostatin pre-mRNAs was beneficial in mdx mice, a mouse model of DMD, although therapeutic effects were muscle type restricted, possibly due to the delivery routes used. Here, following systemic intravascular antisense treatment, muscle strength and body activity of treated adult mdx mice increased to the levels of healthy controls. Importantly, hallmarks of muscular dystrophy were greatly improved in mice receiving the combined exon-skipping therapy, as compared to those receiving dystrophin antisense therapy alone. Our results support the translation of antisense therapy for dystrophin restoration and myostatin inhibition into the clinical setting for DMD." @default.
• W2563676178 created "2017-01-06" @default.
• W2563676178 creator A5004975488 @default.
• W2563676178 creator A5018716724 @default.
• W2563676178 creator A5021085969 @default.
• W2563676178 creator A5023365564 @default.
• W2563676178 creator A5064381774 @default.
• W2563676178 creator A5064867246 @default.
• W2563676178 date "2017-03-01" @default.
• W2563676178 modified "2023-10-15" @default.
• W2563676178 title "Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice" @default.
• W2563676178 cites W1577523494 @default.
• W2563676178 cites W1781484722 @default.
• W2563676178 cites W1888932721 @default.
• W2563676178 cites W1892737480 @default.
• W2563676178 cites W1920407368 @default.
• W2563676178 cites W1964137685 @default.
• W2563676178 cites W1966662292 @default.
• W2563676178 cites W1971189666 @default.
• W2563676178 cites W1983922247 @default.
• W2563676178 cites W1983977163 @default.
• W2563676178 cites W1985467308 @default.
• W2563676178 cites W1987745724 @default.
• W2563676178 cites W1989272637 @default.
• W2563676178 cites W1998004606 @default.
• W2563676178 cites W2002561225 @default.
• W2563676178 cites W2005366749 @default.
• W2563676178 cites W2012621742 @default.
• W2563676178 cites W2018988532 @default.
• W2563676178 cites W2028156358 @default.
• W2563676178 cites W2028966038 @default.
• W2563676178 cites W2035357444 @default.
• W2563676178 cites W2036434973 @default.
• W2563676178 cites W2038428739 @default.
• W2563676178 cites W2053079324 @default.
• W2563676178 cites W2054213109 @default.
• W2563676178 cites W2057293159 @default.
• W2563676178 cites W2062078686 @default.
• W2563676178 cites W2062746471 @default.
• W2563676178 cites W2066180106 @default.
• W2563676178 cites W2068435782 @default.
• W2563676178 cites W2068994927 @default.
• W2563676178 cites W2072088562 @default.
• W2563676178 cites W2076738615 @default.
• W2563676178 cites W2077583368 @default.
• W2563676178 cites W2079586527 @default.
• W2563676178 cites W2083700023 @default.
• W2563676178 cites W2083922607 @default.
• W2563676178 cites W2084480543 @default.
• W2563676178 cites W2086344503 @default.
• W2563676178 cites W2087034573 @default.
• W2563676178 cites W2097680159 @default.
• W2563676178 cites W2107774728 @default.
• W2563676178 cites W2108645449 @default.
• W2563676178 cites W2114952053 @default.
• W2563676178 cites W2116266608 @default.
• W2563676178 cites W2117372474 @default.
• W2563676178 cites W2118646475 @default.
• W2563676178 cites W2141695132 @default.
• W2563676178 cites W2142828130 @default.
• W2563676178 cites W2149993139 @default.
• W2563676178 cites W2153537261 @default.
• W2563676178 cites W2157112460 @default.
• W2563676178 cites W2162938177 @default.
• W2563676178 cites W2165382119 @default.
• W2563676178 cites W2181486330 @default.
• W2563676178 cites W2234725241 @default.
• W2563676178 doi "https://doi.org/10.1016/j.omtn.2016.11.009" @default.
• W2563676178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5363451" @default.
• W2563676178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28325281" @default.
• W2563676178 hasPublicationYear "2017" @default.
• W2563676178 type Work @default.
• W2563676178 sameAs 2563676178 @default.
• W2563676178 citedByCount "24" @default.
• W2563676178 countsByYear W25636761782017 @default.
• W2563676178 countsByYear W25636761782018 @default.
• W2563676178 countsByYear W25636761782019 @default.
• W2563676178 countsByYear W25636761782020 @default.
• W2563676178 countsByYear W25636761782021 @default.
• W2563676178 countsByYear W25636761782022 @default.
• W2563676178 countsByYear W25636761782023 @default.
• W2563676178 crossrefType "journal-article" @default.
• W2563676178 hasAuthorship W2563676178A5004975488 @default.
• W2563676178 hasAuthorship W2563676178A5018716724 @default.
• W2563676178 hasAuthorship W2563676178A5021085969 @default.
• W2563676178 hasAuthorship W2563676178A5023365564 @default.
• W2563676178 hasAuthorship W2563676178A5064381774 @default.
• W2563676178 hasAuthorship W2563676178A5064867246 @default.
• W2563676178 hasBestOaLocation W25636761781 @default.
• W2563676178 hasConcept C104317684 @default.
• W2563676178 hasConcept C126322002 @default.
• W2563676178 hasConcept C134018914 @default.
• W2563676178 hasConcept C14363569 @default.
• W2563676178 hasConcept C194583182 @default.
• W2563676178 hasConcept C2777300911 @default.
• W2563676178 hasConcept C2777488582 @default.
• W2563676178 hasConcept C2778750056 @default.
• W2563676178 hasConcept C2778776201 @default.

• next